Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 8Carcinoma, Ovarian Epithelial 3Neoplasms 2Fallopian Tube Neoplasms 2Kenny-Caffey syndrome, Type 1 1Carcinoma 1Advanced Ovarian Cancer 1

Interventions

Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 5Blood Specimen Collection 4niraparib 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Microarray Analysis 3Flow Cytometry 3Therapeutics 2Immunoenzyme Techniques 2Gene Expression Profiling 2DNA Methylation 2rucaparib 1envafolimab 1Watchful Waiting 1Surgical Procedures, Operative 1Ropivacaine 1Papanicolaou Test 1Paclitaxel 1Neoadjuvant Therapy 1Mass Spectrometry 1Liquid Biopsy 1In Situ Hybridization, Fluorescence 1Hysterectomy 1Hyperthermic Intraperitoneal Chemotherapy 1Hydromorphone 1High-Energy Shock Waves 1Geriatric Assessment 1Genetic Profile 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Carcinoma, Ovarian Epithelial × niraparib × Clear all
NCT06086665 2026-02-04

REFIRM

Asan Medical Center

Completed
850 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT04546373 2021-08-05

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Grupo Español de Investigación en Cáncer de Ovario

Completed
316 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04986371 2021-08-02

RENI-1

ChineseAMS

Unknown
300 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡